SCHEMBL4174172

SCHEMBL4174172

N#C/C(=C/c1cc(F)cc(F)c1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ KMT2A Q03164 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ ALPG P10696 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ BRAF P15056 2/20 0.41
▸ PPME1 Q9Y570 1/20 0.38
▸ EGFR P00533 3/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4174167 1.00 PKM (0.49) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4174176 1.00 PKM (0.49) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4184669 0.81 ALDH1A1 (0.46) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4183778 0.81 LMNA (0.58) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4184666 0.81 ALDH1A1 (0.46) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4184673 0.81 ALDH1A1 (0.46) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4183775 0.81 LMNA (0.58) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4183780 0.81 LMNA (0.58) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4179371 0.80 KDM4E (0.51) PKML3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL4179378 0.80 KDM4E (0.51) PKML3MBTL1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 PKM 2657/4885L3MBTL1 3476/4885KMT2A 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback